Atrium Therapeutics Inc (RNA)

SG&A Expenses

$60.44M

TTM · Period ending: · USD

RNA logo

RNA SG&A Expenses

Latest reported$60.44M
RNA TTM SG&A Expenses ($60.44M → $60.44M)
More history is needed to export this chart.

RNA sg&a expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Atrium Therapeutics Inc SG&A Expenses — Trailing twelve months (TTM) (USD)
Period endingSG&A Expenses (USD)
60,440,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.